“This expansion is a milestone in our journey to deliver world-class expertise with local insights,” said Tanya van der Wall, Managing Director, JAPAC.
“Our strengthened presence in Japan/Asia Pacific (JAPAC) allows us to elevate client services and foster collaboration across global and regional markets. This office will serve as a hub for local expertise and talent, strategy, and partnership, ensuring continued growth and success."
Initial focus and expertise will be safety & vigilance and regulatory affairs including case processing, signal detection, literature surveillance, medical technical writing, regulatory strategy and new product registrations (J-NDA) approval for clinical trials, lifecycle maintenance and compliance, and PMDA consultations. The office will host local experts with both English and Japanese language proficiencies.